ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Arbutus Biopharma Corporation

Arbutus Biopharma Corporation (ABUS)

3.44
-0.01
(-0.29%)
Al cierre: 26 Febrero 3:00PM
3.44
0.01
( 0.29% )
Fuera de horario: 4:07PM

Calls

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
1.001.005.000.003.000.000.00 %00-
1.500.703.900.002.300.000.00 %00-
2.000.705.001.272.850.000.00 %0111-
2.500.854.800.902.8250.000.00 %027-
3.000.500.550.600.525-0.05-7.69 %780911:16:35
3.500.150.250.200.20-0.05-20.00 %431,97509:19:04
4.000.050.100.050.075-0.02-28.57 %3283808:49:23
4.500.050.050.050.050.000.00 %0287-
5.000.050.250.050.150.000.00 %0524-
5.500.000.050.000.000.000.00 %00-
6.000.080.250.080.1650.000.00 %0331-

Herramientas de nivel profesional para inversores individuales.

Puts

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
1.000.000.750.000.000.000.00 %00-
1.500.000.750.000.000.000.00 %00-
2.000.000.750.000.000.000.00 %00-
2.500.000.200.000.000.000.00 %00-
3.000.110.100.050.105-0.06-54.55 %256708:37:42
3.500.200.350.250.2750.1066.67 %651,32614:29:26
4.000.501.750.801.1250.000.00 %0815-
4.500.802.001.361.400.000.00 %070-
5.001.454.700.003.0750.000.00 %00-
5.500.803.400.002.100.000.00 %00-
6.002.403.200.002.800.000.00 %00-

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ULYUrgent ly Inc
US$ 0.85
(102.38%)
6.04M
CPOPPop Culture Group Company Ltd
US$ 1.34
(93.64%)
9.16M
BLMZBloomZ Inc
US$ 0.509
(41.47%)
6.82M
NIXXNixxy Inc
US$ 2.12
(34.18%)
7.82M
ICCTiCoreConnect Inc
US$ 1.29
(18.35%)
124.35k
DMRCDigimarc Corporation
US$ 20.50
(-24.19%)
36.08k
SYTASiyata Mobile Inc
US$ 3.28
(-21.34%)
491.19k
SPGCSacks Parente Golf Inc
US$ 0.5799
(-20.79%)
1.44M
PITAHeramba Electric PLC
US$ 0.5537
(-19.58%)
1.5M
TNDMTandem Diabetes Care Inc
US$ 27.6498
(-17.68%)
308.08k
NVDANVIDIA Corporation
US$ 131.20
(-0.06%)
39.73M
CPOPPop Culture Group Company Ltd
US$ 1.34
(93.64%)
9.16M
NIXXNixxy Inc
US$ 2.12
(34.18%)
7.82M
BLMZBloomZ Inc
US$ 0.509
(41.47%)
6.82M
CLEUChina Liberal Education Holdings Ltd
US$ 0.0645
(-13.19%)
6.64M

ABUS Discussion

Ver más
db7 db7 1 día hace
"The Company will temporarily pause participation in investor meetings and conferences while the new board and management team reviews development plans and strategic options for its hepatitis B programs."
👍️0
db7 db7 1 día hace
https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-announces-changes-board-directors-and-appointment
👍️0
db7 db7 5 días hace
Whitefort message and adding: https://www.sec.gov/Archives/edgar/data/1447028/000092189525000560/xslSCHEDULE_13D_X01/primary_doc.xml
👍️0
db7 db7 1 semana hace
ROIV filed sc-13d yesterday: "Roivant and its representatives are evaluating potential near-term changes to the composition of the board of directors and management of the Issuer. Roivant's representatives may also be engaged in discussions related to such potential changes in the board of directors and management of the Issuer with other shareholders of the Issuer. "
👍️0
Monksdream Monksdream 2 semanas hace
ABUS under $4

👍️0
MWM MWM 1 mes hace
ABUS made it on mad money tonight, the ultimate spec! 

https://www.cnbc.com/2025/01/13/cramers-lightning-round-arbutus-biopharma-is-the-ultimate-spec.html

👍️ 1
MWM MWM 1 mes hace
I'll look now 👍🏽
👍️0
db7 db7 1 mes hace
MWM see today’s update. Qilu milestones coming and no more atm

Pfizer Markman results ‘soon’. Assuming they are positive we should have liftoff. ATM program killed the Moderna Markman last year and won’t be used during Pfizer results it sounds like

Now to just get a decisive victory!?!???
👍️0
db7 db7 3 meses hace
nice new Blackrock 13F: https://stocktwits.com/bs010101/message/592459944
👍️0
db7 db7 3 meses hace
2 days to AASLD...
👍️0
mick mick 4 meses hace
👍️0
db7 db7 4 meses hace
2 late breakers for AASLD: https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-announces-multiple-abstracts-highlighting-imdusiran-data
👍️0
mick mick 5 meses hace
https://www.stockscores.com/charts/charts/?ticker=ABUS
👍️0
mick mick 6 meses hace
ABUS
Arbutus Biopharma Corporation
4.5488
0.0388 (0.86%)
Volume: 1,579,948
Day Range: 4.39 - 4.56
Last Trade Time: 7:46:00 PM EDT
👍️0
db7 db7 6 meses hace
breaking out; dare i say 'someone' knows 'something'(?)
👍️0
db7 db7 6 meses hace
ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al "Please take notice that an in-person Markman Hearing is hereby scheduled for 12/18/2024 at 10:30AM in Trenton- Courtroom 4W. So Ordered by Judge Zahid N. Quraishi on 9/3/2024. (kas)"
👍️0
db7 db7 6 meses hace
ABUS over $4
👍️0
Monksdream Monksdream 6 meses hace
ABUS under $4
👍️0
DewDiligence DewDiligence 7 meses hace
ABUS pares pipeline–reduces workforce 40%:

https://finance.yahoo.com/news/arbutus-reports-second-quarter-2024-113000099.html

The company’s will focus on clinical development of Imdusiran regimens for HBV, but will terminate research on new HBV compounds.

Oddly (for the reason mentioned at the bottom of #msg-174556022), ABUS opted to retain its oral PD-1 program.
👍️0
Rockurstocks Rockurstocks 7 meses hace
Not for long! $ABUS$
👍️0
Monksdream Monksdream 7 meses hace
ABUS under $4
👍️0
mick mick 7 meses hace
ABUS
Arbutus Biopharma Corporation
3.645
-0.135 (-3.57%)
Volume: 449,700
Day Range: 3.645 - 3.845
Last Trade Time: 2:29:04 PM EDT
👍️0
Monksdream Monksdream 7 meses hace
ABUS new 52/week high
👍️0
db7 db7 8 meses hace
👍️0
db7 db7 9 meses hace
https://www.sec.gov/Archives/edgar/data/1447028/000089542124000390/ArbutusABUS.txt
👍️0
db7 db7 9 meses hace
New Presentation: https://investor.arbutusbio.com/static-files/f33bde13-92b8-48c4-a40e-36cf6dd25852
👍️0
db7 db7 9 meses hace
Poster for EASL https://www.arbutusbio.com/wp-content/uploads/2024/06/WED-371-Yuen-et-al-AB-729-201-IFN-poster-EASL-2024_FINAL.pdf
👍️0
mick mick 9 meses hace
ABUS
Arbutus Biopharma Corporation
3.341
-0.019 (-0.57%)
Volume: 534,638
Day Range: 3.30 - 3.385
Last Trade Time: 12:14:00 PM EDT
Delayed by 15 minutes
👍️0
db7 db7 9 meses hace
EASL June 6-8th:
https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-present-imdusiran-data-easl-congress-2024

"
HBsAg = LLOQ (lower limit of quantification) with detectable anti-HBs was observed at end-of-treatment in 28% of subjects who received 4 or 6 doses of imdusiran plus 24 weeks of IFN
"
👍️0
db7 db7 9 meses hace
Arbutus is waking up a little following yesterday's Motion to Dismiss with Acuitas:
https://www.law360.com/ip/articles/1839088/judge-tosses-acuitas-covid-biotech-ip-suit-

other important events of late include:

1) company stating they have stopped their ATM and don't see a need to use it the rest of this year

2) the Markman order against Moderna that went in their favor:
https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-biopharma-announces-claim-construction-ruling-its

3) Activist becoming involved:
https://www.morningstar.com/news/business-wire/20240517970994/whitefort-capital-publishes-open-letter-to-arbutus-biopharma-shareholders-outlining-paths-to-maximize-value
👍️0
db7 db7 9 meses hace
issue here, now, might be too many open $3 calls? will mm's hold her under....
👍️0
db7 db7 9 meses hace
mgmt killed this stock with that ATM; imo, used in a suspicious manner... ie: they put a lid on her on the markman order release at $3ish .. WHY would you do that? They could have raised same money at double the price
👍️0
MWM MWM 9 meses hace
Nice!
👍️0
db7 db7 9 meses hace
https://www.businesswire.com/news/home/20240517970994/en/
👍️0
db7 db7 10 meses hace
from Whitefort's 13D filed today: "The Reporting Persons have conveyed their view to the Issuer’s Board of Directors (the “Board”) that the current market price of the Shares does not reflect the Issuer’s intrinsic value. The Reporting Persons have requested that the Board immediately terminate the Issuer’s ATM program and explore all strategic options for the Issuer’s hepatitis B virus (HBV) portfolio. The Reporting Persons hope to continue to work constructively and collaboratively with the Board on these critical initiatives and intend to actively engage with shareholders and others regarding their views."
👍️0
Monksdream Monksdream 10 meses hace
ABUS under $3
👍️0
mick mick 10 meses hace
TWTR
Twitter Inc
53.70
0.00 (0.00%)
Volume:
👍️0
Monksdream Monksdream 11 meses hace
ABUS new 52 hi
👍️0
db7 db7 11 meses hace
looking a little better today; i guess it's going to be slow and steady and not the rocket on markman day like i hoped. i think this is looking really good med-long term on the litigation from after that markman ruling

also, looking forward to EASL in june
👍️0
mick mick 11 meses hace
ABUS
Arbutus Biopharma Corporation
3.00
0.08 (2.74%)
Volume: 1,253,240
Day Range: 2.86 - 3.11
Bid: 2.99
Ask: 3.00
Last Trade Time: 9:56:51 AM EDT
Total Trades: 3,890
👍️0
mick mick 11 meses hace
ABUS
Arbutus Biopharma Corporation
3.00
0.08 (2.74%)
Volume: 1,253,240
Day Range: 2.86 - 3.11
Bid: 2.99
Ask: 3.00
Last Trade Time: 9:56:51 AM EDT
Total Trades: 3,890
👍️0
mick mick 11 meses hace
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
03/05/2024 04:48:49 PM
👍️0
mick mick 11 meses hace
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
03/05/2024 04:48:49 PM
👍️0
mick mick 11 meses hace
Arbutus to Participate in Two Upcoming Investor Conferences
03/08/2024 07:30:00 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
03/05/2024 04:48:49 PM
👍️0
mick mick 11 meses hace
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
04/04/2024 08:30:49 AM
Arbutus to Participate in Two Upcoming Investor Conferences
03/08/2024 07:30:00 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
03/05/2024 04:48:49 PM
👍️0
Paullee Paullee 11 meses hace
07:15 AM EDT, 04/04/2024 (MT Newswires) -- A US court ruled against Moderna (MRNA) in a patent infringement case by Arbutus (ABUS) over its COVID-19 vaccines, Reuters reported Wednesday.

US District Judge Mitchell Goldberg interpreted the patents in ways that favored Arbutus' case and hurt Moderna', Reuters reported.

Arbutus sued Moderna in 2022, claiming the company's COVID-19 vaccine impinged on its patents for lipid nanoparticles that shield the vaccine's mRNA from the body's immune system.

Moderna and Arbutus did not immediately respond to MT Newswires' requests for comment.
👍️0
MWM MWM 11 meses hace
Watching all 3 stocks. $ABUS is kind of moving...
👍️0
db7 db7 11 meses hace
was going to take all '3' to explode imo..
👍️0
MWM MWM 11 meses hace
Yes, I'm trying to read it myself
👍️0
db7 db7 11 meses hace
decision is out; looks like arbutus won '2' and moderna '1' .. please confirm
👍️0